Skip to main content
Sarepta Therapeutics, Inc. logo

Sarepta Therapeutics, Inc. — Investor Relations & Filings

Ticker · SRPT ISIN · US8036071004 LEI · 549300IKDPIED8J8IG21 US Manufacturing
Filings indexed 1,061 across all filing types
Latest filing 2022-03-02 Director's Dealing
Country US United States of America
Listing US SRPT

About Sarepta Therapeutics, Inc.

https://www.sarepta.com/

Sarepta Therapeutics is a commercial-stage biopharmaceutical company that engineers precision genetic medicines for rare diseases. The company's research and development efforts are centered on RNA-targeted therapeutics and gene therapies, with a primary focus on treating rare neuromuscular and central nervous system disorders. Sarepta aims to accelerate the drug development process from discovery to patient application and is building significant gene therapy manufacturing capabilities to support its mission.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2022-03-02 English
10-K
Annual Report FY 2021
2022-03-01 English
SC 13G
Major Shareholding Notification
2022-02-12 English
JANUS HENDERSON GROUP PLC OWNS >5%
Major Shareholding Notification
2022-02-11 English
SCHEDULE 13G/A
Major Shareholding Notification
2022-02-10 English
Major Shareholding Notification 2022
Major Shareholding Notification
2022-02-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.